These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 15765203

  • 1. Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
    Lambert-Messerlian G, Pinar H, Rubin LP, De Paepe ME, Tantravahi U, Steinhoff MM, Russell M, Canick JA.
    Pediatr Dev Pathol; 2005; 8(2):230-4. PubMed ID: 15765203
    [Abstract] [Full Text] [Related]

  • 2. Second trimester serum markers.
    Canick JA, MacRae AR.
    Semin Perinatol; 2005 Aug; 29(4):203-8. PubMed ID: 16104669
    [Abstract] [Full Text] [Related]

  • 3. Triploidy identified through second-trimester serum screening.
    Huang T, Alberman E, Wald N, Summers AM.
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [Abstract] [Full Text] [Related]

  • 4. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
    Davidson EJ, Riley SC, Roberts SA, Shearing CH, Groome NP, Martin CW.
    BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
    [Abstract] [Full Text] [Related]

  • 5. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
    Huttly W, Rudnicka A, Wald NJ.
    Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
    [Abstract] [Full Text] [Related]

  • 6. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 7. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
    Groutz A, Amit A, Yaron Y, Yovel I, Wolman I, Legum C, Lessing JB.
    Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
    [Abstract] [Full Text] [Related]

  • 8. Quad screen as a predictor of adverse pregnancy outcome.
    Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH, Saade G, Eddleman K, Merkatz IR, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, FASTER Trial Research Consortium.
    Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
    [Abstract] [Full Text] [Related]

  • 9. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium.
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [Abstract] [Full Text] [Related]

  • 10. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
    Maymon R, Cuckle H, Jones R, Reish O, Sharony R, Herman A.
    Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
    [Abstract] [Full Text] [Related]

  • 11. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 12. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [Abstract] [Full Text] [Related]

  • 13. Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.
    Lambert-Messerlian GM, Saller DN, Tumber MB, French CA, Peterson CJ, Canick JA.
    Prenat Diagn; 1998 Oct; 18(10):1061-7. PubMed ID: 9826898
    [Abstract] [Full Text] [Related]

  • 14. Androgenetic complete mole coexistent with a twin live fetus.
    Matsui H, Iitsuka Y, Ishii J, Osada H, Seki K, Sekiya S.
    Gynecol Oncol; 1999 Aug; 74(2):217-21. PubMed ID: 10419734
    [Abstract] [Full Text] [Related]

  • 15. Second-trimester maternal serum analyte levels associated with fetal trisomy 13.
    Saller DN, Canick JA, Blitzer MG, Palomaki GE, Schwartz S, Blakemore KJ, Haddow JE.
    Prenat Diagn; 1999 Sep; 19(9):813-6. PubMed ID: 10521837
    [Abstract] [Full Text] [Related]

  • 16. Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies.
    Garchet-Beaudron A, Dreux S, Leporrier N, Oury JF, Muller F, ABA Study Group, Clinical Study Group.
    Prenat Diagn; 2008 Dec; 28(12):1105-9. PubMed ID: 19003979
    [Abstract] [Full Text] [Related]

  • 17. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD, McIntosh SF, Halstead AC.
    Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
    [Abstract] [Full Text] [Related]

  • 18. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H, Neri A, Bar J, Regev D, Nordenberg J, Ovadia J.
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [Abstract] [Full Text] [Related]

  • 19. Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome.
    Lambert-Messerlian GM, Canick JA.
    Semin Reprod Med; 2004 Aug; 22(3):235-42. PubMed ID: 15319826
    [Abstract] [Full Text] [Related]

  • 20. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome.
    Muller F, Dreux S, Lemeur A, Sault C, Desgrès J, Bernard MA, Giorgetti C, Lemay C, Mirallié S, Beauchet A, French Collaborative Group.
    Prenat Diagn; 2003 Dec 30; 23(13):1073-6. PubMed ID: 14691995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.